On August 12, 2024, C Richards, Executive Vice President and Chief Financial Officer of Pediatrix Medical Group Inc (NYSE:MD), sold 50,000 shares of the company’s stock. The transaction was documented in a recent SEC filing. Following this sale, the insider now owns 175,347 shares of the company’s stock.
Pediatrix Medical Group Inc (NYSE:MD) specializes in the provision of hospital-based maternal, newborn and pediatric medical services. The company’s network includes clinicians and experienced practitioners who provide care in a variety of high-demand pediatric and obstetric specialties.
Over the past year, according to the insider’s transaction history, C Richards has sold a total of 50,000 shares and made no purchases. The overall insider transaction trend for Pediatrix Medical Group Inc (NYSE:MD) shows 0 insider purchases and 3 insider sales during the same period.
On the day of the sale, Pediatrix Medical Group Inc (NYSE:MD) shares were trading at $10.08. This price puts the company’s market capitalization at approximately $868.106 million.
The stock’s valuation metrics, including GF Value of $15.63, suggest a Price to GF Value ratio of 0.64, suggesting the stock is a possible value trap. Think again. GF Value is calculated using historical multiples such as price-to-earnings ratio, price-to-sales ratio, price-to-book ratio, and price-to-free cash flow along with a GuruFocus adjustment factor and future business performance estimates from Morningstar analysts.
This insider sale may be of interest to current and prospective investors as it provides insight into management confidence and market perception of Pediatrix Medical Group Inc (NYSE:MD).
This article created by GuruFocus is intended to provide general insights and does not constitute tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment advice. It does not contain a recommendation to buy or sell any stock and does not take into account any individual investment objectives or financial circumstances. Our goal is to provide long-term, fundamental, data-driven analysis. Note that our analysis may not include the most recent, price-sensitive company announcements or qualitative information. GuruFocus does not hold a position in any stocks mentioned here.
This article first appeared on GuruFocus.
